2412.01 Overview of the Sequence Rules [R-07.2022]

[Editor Note: This section is applicable to all applications filed on or after July 1, 2022, having disclosures of nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]

Under the sequence listing rules, an applicant is required to submit sequence data, relating to certain nucleotide and/or amino acid sequences disclosed in patent applications that were filed on or after July 1, 2022, in eXtensible Markup Language (XML) format, where the XML file of the sequence information conforms to the requirements of 37 CFR 1.831 – 1.834, which specify requirements of particular paragraphs of WIPO Standard ST.26.